Translating Aging
Decoding Stem Cell Rejuvenation Factors (Markus Gstöttner, CEO of Clock.bio)
Nov 20, 2024
Markus Gstöttner, CEO of Clock.bio, brings his diverse experience from public service and cultured meat entrepreneurship to the forefront of stem cell research. He discusses groundbreaking work on induced pluripotent stem cells (iPSCs) that may reverse aging effects. Gstöttner reveals significant findings from a genetic screen identifying over 150 rejuvenation-related genes. The conversation also highlights the potential of strategic partnerships and drug repurposing in advancing therapies aimed at extending healthspan and tackling age-related diseases.
26:46
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Markus Gstöttner's journey into biotechnology illustrates the synergy between entrepreneurship and public service in advancing healthspan research.
- Clock.bio's innovative approach to studying iPSCs highlights the potential of identifying rejuvenation genes for developing effective longevity therapies.
Deep dives
Markus Kustetner's Journey into Biotech
Markus Kustetner, CEO of ClockBio, shares his unique path into the biotech industry, highlighting a dual passion for entrepreneurship and public service. Initially intrigued by the cultured meat sector after listening to a podcast, he collaborated with a young scientist to co-found Meetable, focusing on innovative meat production technologies. His experience in government and advisory positions in Austria provided him with insights that ultimately fueled his return to the biotech field. This journey has culminated in his leadership at ClockBio, where he aims to leverage the biology of rejuvenation to improve health span.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
